HYAL2 and ovarian endometrioid adenocarcinoma: For patients with endometrioid ovarian cancer expression of HYAL2 (HR = 0.17, p-value = 5.00 × 10–4) and PH20 (HR = 0.3, p-value = 0.015) was associated with better PFS (Tables 3, 4).